Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Anticancer Research|August 6, 2005
Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cellsYoshiyuki Yamaguchi, Koji Ohta, Yoshiharu Kawabuchi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2003
[Generation of TRiDAK (tumor RNA-introduced dendritic cell-activated killer) cells]Akiko Ohshita, Yoshiyuki Yamaguchi, Kazuhito Minami, et al.Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|April 30, 2005
A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancerYoichi Hamai, Shunji Matsumura, Keisuke Matsusaki, et al.Hiroshima Journal of Medical Sciences|January 10, 2006
Intractable gastrointestinal bleeding from angiodysplasia in a patient of Bernard-Soulier syndrome--report of a case--Riki Okita, Jun Hihara, Kazuo Konishi, et al.Japanese Journal of Clinical Oncology|August 31, 2004
A randomized phase II clinical trial of tailored CPT-11 + S-1 vs S-1 in patients with advanced or recurrent gastric carcinoma as the first line chemotherapyYutaka Takahashi, Junichi Sakamoto, Tetsuo Takeuchi, et al.Journal of Cancer Research and Clinical Oncology|February 27, 2004
A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancerShunji Matsumura, Naohide Oue, Yasuhiko Kitadai, et al.International Journal of Clinical Oncology|February 25, 2005
A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumorsToshiaki Saeki, Shigemitsu Takashima, Masanori Terashima, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 28, 2005
[Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)]Takeshi Tominaga, Yasuo Nomura, Noboru Horikoshi, et al.International Journal of Cancer|July 9, 2004
Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genesTomotaka Tanaka, Keiji Tanimoto, Keiko Otani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgeryTakeshi Tominaga, Hiroki Koyama, Tetsuya Toge, et al.Pageof 9